Standout Papers

A comprehensive review on time-tested anticancer drug doxorubicin 2021 2026 2022 2024287
  1. A comprehensive review on time-tested anticancer drug doxorubicin (2021)
    Sruthi Sritharan, N Sivalingam Life Sciences

Citation Impact

35 standout
Sub-graph 1 of 17

Citing Papers

Role of SLC7A11/xCT in Ovarian Cancer
2024 Standout
Autophagy-driven regulation of cisplatin response in human cancers: Exploring molecular and cell death dynamics
2024 Standout
2 intermediate papers

Works of Sruthi Sritharan being referenced

A comprehensive review on time-tested anticancer drug doxorubicin
2021 Standout
Curcumin induces chemosensitization to doxorubicin in Duke’s type B coloadenocarcinoma cell line
2020

Author Peers

Author Oncology CCM Biomaterials Molecular Biology Biomedical Engineering Last Decade Papers Cites
Sruthi Sritharan 64 50 76 145 72 7 332
Robert D. McAlpine 3 1 16 54 32 412
Yazdan Hamzavi 1 7 35 441
Charles W. Eagles 30 135
Y. Eldeberky 1 15 424
Shiloh R. Lueschow 31 2 151 15 13 464

All Works

Loading papers...

Rankless by CCL
2026